Artificial Cells, Blood Substitutes, and Biotechnology
Abbreviated title (ISO 4) | ABB |
|---|---|
| Discipline | Biochemistry/Biotechnology |
| Language | English |
| Edited by | Thomas M.S. Change, O.C. M.D., C.M., Ph.D., FRCP(C), FRS(C) |
| Publication details | |
| Publisher |
Informa Healthcare (UK) |
Publication history | 1973–present |
| Frequency | 8 issues per year |
| no | |
| Indexing | |
| ISSN |
1532-4184 (print) 1073-1199 (web) |
| Links | |
Artificial Cells, Blood Substitutes, and Biotechnology is an academic journal that publishes review articles on the development of artificial cells, tissue engineering, artificial organs, blood substittues, cell therapy, gene and drug delivery systems, bioencapsulation nanosensors, nanodevices and other areas of biotechnology. It is published by Informa Healthcare.
Core Areas
- Tissues and organs
- Artificial cells
- Molecules
- Blood substitutes
- Tissue engineering
- Stem cells
- Gene therapy
- Drug delivery
Editor-in-Chief
Thomas M.S. Chang, O.C., M.D., C.M., Ph.D., FRCP(C), FRS(C) is the Editor-in-Chief of Artificial Cells,
Blood Substitutes, and Biotechnology.[1]
Publication Format
Artificial Cells, Blood Substitutes, and Biotechnology publishes 8 issues per year in simultaneous print and online editions.
References
- ↑ "Editorial Board Members". informhealthcare.com. Retrieved 2009-09-16.
External links
- Artificial Cells, Blood Substitutes, and Biotechnology homepage of Artificial Cells Blood Substitutes and Biotechnology
This article is issued from Wikipedia - version of the 9/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.